goat anti human igf2 polyclonal antibody Search Results


94
R&D Systems goat anti human igf2 polyclonal antibody
Goat Anti Human Igf2 Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/Human+IGF-II%2FIGF2+Antibody/pmc04262567-111-6-11
Average 94 stars, based on 1 article reviews
goat anti human igf2 polyclonal antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
Bioss monoclonal rabbit anti igf2 antibody
Monoclonal Rabbit Anti Igf2 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/IGF2+(1T3)+Monoclonal+Antibody/10__3390_slash_app8050777-66-10-15
Average 92 stars, based on 1 article reviews
monoclonal rabbit anti igf2 antibody - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
US Biological Life Sciences mouse anti-human igf-2 antibody (anti-igf-2)
Mouse Anti Human Igf 2 Antibody (Anti Igf 2), supplied by US Biological Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/mouse+anti+human+ifn++receptor+ii/pm12586351-22-0-13
Average 90 stars, based on 1 article reviews
mouse anti-human igf-2 antibody (anti-igf-2) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
R&D Systems growth factor 2
Growth Factor 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/Human+IGF-II%2FIGF2+Antibody/pm30584802-65-67-72
Average 93 stars, based on 1 article reviews
growth factor 2 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Proteintech anti igf2bp2 antibody
Anti Igf2bp2 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/IGF2BP2+Antibody/ppr0759936-300-14-17
Average 96 stars, based on 1 article reviews
anti igf2bp2 antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
R&D Systems mouse anti human igf2 mab
IGF-2 protein localized in relation to blood vessels in common and congenital hemangioma. A–C) CD31 immunostaining of frozen sections highlights blood vessels in proliferating common hemangioma (A), NICH (B) and RICH (C). Nuclei are stained blue with DAPI. D–E) Common hemangioma sections double-labeled with <t>anti-IGF2</t> (green) and anti-CD31 (red). Nuclei stained with DAPI (blue). Panel D, a proliferating phase hemangioma while Panel E, involuting phase hemangioma. F) RICH double-labeled with anti-IGF2 (green) and anti-CD31 (red). G) NICH stained with anti-IGF2 (green). H) Pyogenic granuloma stained with anti-IGF2 (green) as negative control. Scale bars are 50 µm. Panel A is 200X magnification; Panels B, C, G and H, 100X magnification; Panels D–F, 300X magnification.
Mouse Anti Human Igf2 Mab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/Human+IGF-II+R%2FIGF2R+Antibody/pmc02810617-74-48-53
Average 90 stars, based on 1 article reviews
mouse anti human igf2 mab - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

97
Proteintech mouse antismn
IGF-2 protein localized in relation to blood vessels in common and congenital hemangioma. A–C) CD31 immunostaining of frozen sections highlights blood vessels in proliferating common hemangioma (A), NICH (B) and RICH (C). Nuclei are stained blue with DAPI. D–E) Common hemangioma sections double-labeled with <t>anti-IGF2</t> (green) and anti-CD31 (red). Nuclei stained with DAPI (blue). Panel D, a proliferating phase hemangioma while Panel E, involuting phase hemangioma. F) RICH double-labeled with anti-IGF2 (green) and anti-CD31 (red). G) NICH stained with anti-IGF2 (green). H) Pyogenic granuloma stained with anti-IGF2 (green) as negative control. Scale bars are 50 µm. Panel A is 200X magnification; Panels B, C, G and H, 100X magnification; Panels D–F, 300X magnification.
Mouse Antismn, supplied by Proteintech, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/IGF2BP1+Antibody/10__1523_slash_jneurosci__1002___22__2023-56-47-65
Average 97 stars, based on 1 article reviews
mouse antismn - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
Proteintech rabbit polyclonal anti ci mpr
IGF-2 protein localized in relation to blood vessels in common and congenital hemangioma. A–C) CD31 immunostaining of frozen sections highlights blood vessels in proliferating common hemangioma (A), NICH (B) and RICH (C). Nuclei are stained blue with DAPI. D–E) Common hemangioma sections double-labeled with <t>anti-IGF2</t> (green) and anti-CD31 (red). Nuclei stained with DAPI (blue). Panel D, a proliferating phase hemangioma while Panel E, involuting phase hemangioma. F) RICH double-labeled with anti-IGF2 (green) and anti-CD31 (red). G) NICH stained with anti-IGF2 (green). H) Pyogenic granuloma stained with anti-IGF2 (green) as negative control. Scale bars are 50 µm. Panel A is 200X magnification; Panels B, C, G and H, 100X magnification; Panels D–F, 300X magnification.
Rabbit Polyclonal Anti Ci Mpr, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/IGF2R-Specific+Antibody/bio_rxiv__2024__10__16__618769-128-42-45
Average 94 stars, based on 1 article reviews
rabbit polyclonal anti ci mpr - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
MedChemExpress rabbit anti fto
IGF-2 protein localized in relation to blood vessels in common and congenital hemangioma. A–C) CD31 immunostaining of frozen sections highlights blood vessels in proliferating common hemangioma (A), NICH (B) and RICH (C). Nuclei are stained blue with DAPI. D–E) Common hemangioma sections double-labeled with <t>anti-IGF2</t> (green) and anti-CD31 (red). Nuclei stained with DAPI (blue). Panel D, a proliferating phase hemangioma while Panel E, involuting phase hemangioma. F) RICH double-labeled with anti-IGF2 (green) and anti-CD31 (red). G) NICH stained with anti-IGF2 (green). H) Pyogenic granuloma stained with anti-IGF2 (green) as negative control. Scale bars are 50 µm. Panel A is 200X magnification; Panels B, C, G and H, 100X magnification; Panels D–F, 300X magnification.
Rabbit Anti Fto, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/IGF2BP3%2C+Human/pmc12398073-95-26-4
Average 95 stars, based on 1 article reviews
rabbit anti fto - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
ABclonal Biotechnology antibodies against igf2
Fig. 1 MiR-33a-3p directly targeted <t>IGF2.</t> A A schematic diagram of the forecasted miR-33a-3p binding site to IGF2. B Association between miR-33a-3p and IGF2 was confirmed by dual-luciferase reporter assay. **P < 0.01 versus mimic control
Antibodies Against Igf2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/IGF2+Rabbit+pAb/pm37415192-89-20-26
Average 94 stars, based on 1 article reviews
antibodies against igf2 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
Thermo Fisher mannose 6 phosphate receptor igg2a mab
Fig. 1 MiR-33a-3p directly targeted <t>IGF2.</t> A A schematic diagram of the forecasted miR-33a-3p binding site to IGF2. B Association between miR-33a-3p and IGF2 was confirmed by dual-luciferase reporter assay. **P < 0.01 versus mimic control
Mannose 6 Phosphate Receptor Igg2a Mab, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/Phosphate/pm14971053-96-27-32
Average 99 stars, based on 1 article reviews
mannose 6 phosphate receptor igg2a mab - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
Boster Bio igf 2r
The primers and TaqMan probes of <t> IGF, </t> ER genes used for RT-PCR
Igf 2r, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+human+igf2+polyclonal+antibody/Anti-IGF2R+(Phospho-Ser2484)+Antibody/pmc03503720-123-8-15
Average 90 stars, based on 1 article reviews
igf 2r - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


IGF-2 protein localized in relation to blood vessels in common and congenital hemangioma. A–C) CD31 immunostaining of frozen sections highlights blood vessels in proliferating common hemangioma (A), NICH (B) and RICH (C). Nuclei are stained blue with DAPI. D–E) Common hemangioma sections double-labeled with anti-IGF2 (green) and anti-CD31 (red). Nuclei stained with DAPI (blue). Panel D, a proliferating phase hemangioma while Panel E, involuting phase hemangioma. F) RICH double-labeled with anti-IGF2 (green) and anti-CD31 (red). G) NICH stained with anti-IGF2 (green). H) Pyogenic granuloma stained with anti-IGF2 (green) as negative control. Scale bars are 50 µm. Panel A is 200X magnification; Panels B, C, G and H, 100X magnification; Panels D–F, 300X magnification.

Journal:

Article Title: IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma

doi: 10.1203/PDR.0b013e318163a243

Figure Lengend Snippet: IGF-2 protein localized in relation to blood vessels in common and congenital hemangioma. A–C) CD31 immunostaining of frozen sections highlights blood vessels in proliferating common hemangioma (A), NICH (B) and RICH (C). Nuclei are stained blue with DAPI. D–E) Common hemangioma sections double-labeled with anti-IGF2 (green) and anti-CD31 (red). Nuclei stained with DAPI (blue). Panel D, a proliferating phase hemangioma while Panel E, involuting phase hemangioma. F) RICH double-labeled with anti-IGF2 (green) and anti-CD31 (red). G) NICH stained with anti-IGF2 (green). H) Pyogenic granuloma stained with anti-IGF2 (green) as negative control. Scale bars are 50 µm. Panel A is 200X magnification; Panels B, C, G and H, 100X magnification; Panels D–F, 300X magnification.

Article Snippet: Indirect immunofluorescence Cryosections ( 4 μm ) of the tumors (proliferating and involuting infantile hemangioma), RICH, NICH and pyogenic granulomas were fixed with cold acetone for 15 min. After washing for 5 min in PBS, and incubating with species appropriate blocking serum, the following primary antibodies were used: mouse anti-human IGF2 mAb 1:50 (R&D Systems, USA), mouse anti-human CD31 mAb 1:50 (DAKO, Carpinteria, CA, USA), goat anti-human CD31 antibody 1:50 (Santa Cruz Biotechnology Inc., CA, USA).

Techniques: Immunostaining, Staining, Labeling, Negative Control

Fig. 1 MiR-33a-3p directly targeted IGF2. A A schematic diagram of the forecasted miR-33a-3p binding site to IGF2. B Association between miR-33a-3p and IGF2 was confirmed by dual-luciferase reporter assay. **P < 0.01 versus mimic control

Journal: Journal of orthopaedic surgery and research

Article Title: Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis.

doi: 10.1186/s13018-023-03883-6

Figure Lengend Snippet: Fig. 1 MiR-33a-3p directly targeted IGF2. A A schematic diagram of the forecasted miR-33a-3p binding site to IGF2. B Association between miR-33a-3p and IGF2 was confirmed by dual-luciferase reporter assay. **P < 0.01 versus mimic control

Article Snippet: The membranes were blocked with 5% skimmed milk for 2 h to avoid nonspecific binding and then cultivated with primary antibodies against IGF2 (cat. no. A2086, ABclonal; 1:1000 dilution) or β-actin (cat. no. TDY051; Beijing TDY Biotech CO., LTD.; 1:1000 dilution) at 4 °C overnight.

Techniques: Binding Assay, Luciferase, Reporter Assay, Control

Fig. 3 Expression of miR-33a-3p and IGF2 in osteogenic differentiation induced hBMSCs. A Alizarin red S was applied for detecting calcified cells. B Quantification of calcified cells. C Detection of ALP activity. D RT-qPCR analysis of Runx2, ALP and Osterix mRNA levels. E–G The expression of miR-33a-3p and IGF2 was assessed by western blot analysis or RT-qPCR analysis. *P < 0.05, **P < 0.01, ***P < 0.001 versus Control

Journal: Journal of orthopaedic surgery and research

Article Title: Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis.

doi: 10.1186/s13018-023-03883-6

Figure Lengend Snippet: Fig. 3 Expression of miR-33a-3p and IGF2 in osteogenic differentiation induced hBMSCs. A Alizarin red S was applied for detecting calcified cells. B Quantification of calcified cells. C Detection of ALP activity. D RT-qPCR analysis of Runx2, ALP and Osterix mRNA levels. E–G The expression of miR-33a-3p and IGF2 was assessed by western blot analysis or RT-qPCR analysis. *P < 0.05, **P < 0.01, ***P < 0.001 versus Control

Article Snippet: The membranes were blocked with 5% skimmed milk for 2 h to avoid nonspecific binding and then cultivated with primary antibodies against IGF2 (cat. no. A2086, ABclonal; 1:1000 dilution) or β-actin (cat. no. TDY051; Beijing TDY Biotech CO., LTD.; 1:1000 dilution) at 4 °C overnight.

Techniques: Expressing, Activity Assay, Quantitative RT-PCR, Western Blot, Control

Fig. 2 Expression of miR-33a-3p and IGF2 in the serum of osteoporosis patients. A–B Levels of miR-33a-3p and IGF2 in the serum of osteoporosis patients were checked by RT-qPCR assay.**P < 0.01

Journal: Journal of orthopaedic surgery and research

Article Title: Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis.

doi: 10.1186/s13018-023-03883-6

Figure Lengend Snippet: Fig. 2 Expression of miR-33a-3p and IGF2 in the serum of osteoporosis patients. A–B Levels of miR-33a-3p and IGF2 in the serum of osteoporosis patients were checked by RT-qPCR assay.**P < 0.01

Article Snippet: The membranes were blocked with 5% skimmed milk for 2 h to avoid nonspecific binding and then cultivated with primary antibodies against IGF2 (cat. no. A2086, ABclonal; 1:1000 dilution) or β-actin (cat. no. TDY051; Beijing TDY Biotech CO., LTD.; 1:1000 dilution) at 4 °C overnight.

Techniques: Expressing, Quantitative RT-PCR

Fig. 4 Effects of miR-33a-3p on IGF2 levels in hBMSCs. hBMSCs were transfected with mimic control, miR-33a-3p mimic, inhibitor control or miR-33a-3p inhibitor for 48 h. A Detection of miR-33a-3p levels using RT-qPCR. B–C Expressions of IGF2 were assessed by RT-qPCR and western blot analysis. RT-qPCR analysis of miR-33a-3p (D) and IGF2 (E) mRNA levels in miR-33a-3p inhibitor or inhibitor control transfected cells. F Western blot analysis of miR-33a-3p and IGF2. **P < 0.01 versus Mimic control; ##P < 0.01 versus Inhibitor control

Journal: Journal of orthopaedic surgery and research

Article Title: Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis.

doi: 10.1186/s13018-023-03883-6

Figure Lengend Snippet: Fig. 4 Effects of miR-33a-3p on IGF2 levels in hBMSCs. hBMSCs were transfected with mimic control, miR-33a-3p mimic, inhibitor control or miR-33a-3p inhibitor for 48 h. A Detection of miR-33a-3p levels using RT-qPCR. B–C Expressions of IGF2 were assessed by RT-qPCR and western blot analysis. RT-qPCR analysis of miR-33a-3p (D) and IGF2 (E) mRNA levels in miR-33a-3p inhibitor or inhibitor control transfected cells. F Western blot analysis of miR-33a-3p and IGF2. **P < 0.01 versus Mimic control; ##P < 0.01 versus Inhibitor control

Article Snippet: The membranes were blocked with 5% skimmed milk for 2 h to avoid nonspecific binding and then cultivated with primary antibodies against IGF2 (cat. no. A2086, ABclonal; 1:1000 dilution) or β-actin (cat. no. TDY051; Beijing TDY Biotech CO., LTD.; 1:1000 dilution) at 4 °C overnight.

Techniques: Transfection, Control, Quantitative RT-PCR, Western Blot

Fig. 5 Effects of IGF2-plasmid or miR-33a-3p mimic on IGF2 levels in hBMSCs. hBMSCs were transfected with mimic control, miR-33a-3p mimic, control-plasmid, IGF2-plasmid for 48 h. A–B Determination of IGF2 level in control-plasmid or IGF2-plasmid transfected cells by RT-qPCR and western blot assay. C–D Expressions of IGF2 were assessed by RT-qPCR and western blot analysis. **P < 0.01 versus Control-plasmid; ##P < 0.01 versus Mimic control; &&P < 0.01 versus miR-33a-3p mimic + control-plasmid

Journal: Journal of orthopaedic surgery and research

Article Title: Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis.

doi: 10.1186/s13018-023-03883-6

Figure Lengend Snippet: Fig. 5 Effects of IGF2-plasmid or miR-33a-3p mimic on IGF2 levels in hBMSCs. hBMSCs were transfected with mimic control, miR-33a-3p mimic, control-plasmid, IGF2-plasmid for 48 h. A–B Determination of IGF2 level in control-plasmid or IGF2-plasmid transfected cells by RT-qPCR and western blot assay. C–D Expressions of IGF2 were assessed by RT-qPCR and western blot analysis. **P < 0.01 versus Control-plasmid; ##P < 0.01 versus Mimic control; &&P < 0.01 versus miR-33a-3p mimic + control-plasmid

Article Snippet: The membranes were blocked with 5% skimmed milk for 2 h to avoid nonspecific binding and then cultivated with primary antibodies against IGF2 (cat. no. A2086, ABclonal; 1:1000 dilution) or β-actin (cat. no. TDY051; Beijing TDY Biotech CO., LTD.; 1:1000 dilution) at 4 °C overnight.

Techniques: Plasmid Preparation, Transfection, Control, Quantitative RT-PCR, Western Blot

Fig. 7 Effects of miR-33a-3p mimic or IGF2-plasmid on hBMSCs viability and apoptosis. hBMSCs were transfected with mimic control, miR-33a-3p mimic, control-plasmid, IGF2-plasmid for 48 h. A MTT assay of cell viability. B Cell apoptosis was detected by Flow cytometry assay. C Quantification of apoptotic cells. **P < 0.01 versus mimic control; ##P < 0.01 versus miR-33a-3p mimic + control-plasmid

Journal: Journal of orthopaedic surgery and research

Article Title: Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis.

doi: 10.1186/s13018-023-03883-6

Figure Lengend Snippet: Fig. 7 Effects of miR-33a-3p mimic or IGF2-plasmid on hBMSCs viability and apoptosis. hBMSCs were transfected with mimic control, miR-33a-3p mimic, control-plasmid, IGF2-plasmid for 48 h. A MTT assay of cell viability. B Cell apoptosis was detected by Flow cytometry assay. C Quantification of apoptotic cells. **P < 0.01 versus mimic control; ##P < 0.01 versus miR-33a-3p mimic + control-plasmid

Article Snippet: The membranes were blocked with 5% skimmed milk for 2 h to avoid nonspecific binding and then cultivated with primary antibodies against IGF2 (cat. no. A2086, ABclonal; 1:1000 dilution) or β-actin (cat. no. TDY051; Beijing TDY Biotech CO., LTD.; 1:1000 dilution) at 4 °C overnight.

Techniques: Plasmid Preparation, Transfection, Control, MTT Assay, Flow Cytometry

Fig. 6 Effects of miR-33a-3p mimic or IGF2-plasmid on hBMSCs calcification and ALP activity. hBMSCs were transfected with mimic control, miR-33a-3p mimic, control-plasmid, IGF2-plasmid for 48 h. RT-qPCR analysis and western blot assay of miR-33a-3p (A) and IGF2 (B–C) expression. D Calcified cells were determined by Alizarin Red S. E Quantification of calcified cells. F Evaluation of ALP activity. G mRNA levels of Runx2, ALP and Osterix were detected by RT-qPCR analysis. **P < 0.01 versus Control; ##P < 0.01 versus Induction + mimic control; &&P < 0.01 versus Induction + miR-33a-3p mimic + control-plasmid

Journal: Journal of orthopaedic surgery and research

Article Title: Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis.

doi: 10.1186/s13018-023-03883-6

Figure Lengend Snippet: Fig. 6 Effects of miR-33a-3p mimic or IGF2-plasmid on hBMSCs calcification and ALP activity. hBMSCs were transfected with mimic control, miR-33a-3p mimic, control-plasmid, IGF2-plasmid for 48 h. RT-qPCR analysis and western blot assay of miR-33a-3p (A) and IGF2 (B–C) expression. D Calcified cells were determined by Alizarin Red S. E Quantification of calcified cells. F Evaluation of ALP activity. G mRNA levels of Runx2, ALP and Osterix were detected by RT-qPCR analysis. **P < 0.01 versus Control; ##P < 0.01 versus Induction + mimic control; &&P < 0.01 versus Induction + miR-33a-3p mimic + control-plasmid

Article Snippet: The membranes were blocked with 5% skimmed milk for 2 h to avoid nonspecific binding and then cultivated with primary antibodies against IGF2 (cat. no. A2086, ABclonal; 1:1000 dilution) or β-actin (cat. no. TDY051; Beijing TDY Biotech CO., LTD.; 1:1000 dilution) at 4 °C overnight.

Techniques: Plasmid Preparation, Activity Assay, Transfection, Control, Quantitative RT-PCR, Western Blot, Expressing

The primers and TaqMan probes of  IGF,  ER genes used for RT-PCR

Journal: BMC Cancer

Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression

doi: 10.1186/1471-2407-12-262

Figure Lengend Snippet: The primers and TaqMan probes of IGF, ER genes used for RT-PCR

Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China), IGF-2R (polyclonal rabbit anti-human IGF-2R, 1:50 dilution, Wuhan Boster .

Techniques:

The mRNA levels of IGF-1,  IGF-1R,  IGF-2,  IGF-2R,  IGFBP-3, ERα and ERβ in EAC, tumor-adjacent, and control groups

Journal: BMC Cancer

Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression

doi: 10.1186/1471-2407-12-262

Figure Lengend Snippet: The mRNA levels of IGF-1, IGF-1R, IGF-2, IGF-2R, IGFBP-3, ERα and ERβ in EAC, tumor-adjacent, and control groups

Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China), IGF-2R (polyclonal rabbit anti-human IGF-2R, 1:50 dilution, Wuhan Boster .

Techniques: Control

The immunostaining of  IGF-1R,   IGF-2R,  ERα and ERβ in EAC, atypical hyperplasia, and control groups

Journal: BMC Cancer

Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression

doi: 10.1186/1471-2407-12-262

Figure Lengend Snippet: The immunostaining of IGF-1R, IGF-2R, ERα and ERβ in EAC, atypical hyperplasia, and control groups

Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China), IGF-2R (polyclonal rabbit anti-human IGF-2R, 1:50 dilution, Wuhan Boster .

Techniques: Immunostaining, Control, Positive Control

The relationship between the  IGF  and ER mRNA expression and clinico-pathological features of endometrioid adenocarcinoma

Journal: BMC Cancer

Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression

doi: 10.1186/1471-2407-12-262

Figure Lengend Snippet: The relationship between the IGF and ER mRNA expression and clinico-pathological features of endometrioid adenocarcinoma

Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China), IGF-2R (polyclonal rabbit anti-human IGF-2R, 1:50 dilution, Wuhan Boster .

Techniques: Expressing

The relationship between the  IGF-1R,   IGF2R,  ERα and ERβ protein expression and clinico-pathological features of endometrioid adenocarcinoma

Journal: BMC Cancer

Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression

doi: 10.1186/1471-2407-12-262

Figure Lengend Snippet: The relationship between the IGF-1R, IGF2R, ERα and ERβ protein expression and clinico-pathological features of endometrioid adenocarcinoma

Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China), IGF-2R (polyclonal rabbit anti-human IGF-2R, 1:50 dilution, Wuhan Boster .

Techniques: Expressing

Correlation analysis of  IGF  and ER mRNA expression with clinico-pathological features of EAC

Journal: BMC Cancer

Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression

doi: 10.1186/1471-2407-12-262

Figure Lengend Snippet: Correlation analysis of IGF and ER mRNA expression with clinico-pathological features of EAC

Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China), IGF-2R (polyclonal rabbit anti-human IGF-2R, 1:50 dilution, Wuhan Boster .

Techniques: Expressing

Correlation analysis of  IGF-1R,   IGF-2R,  and ERα and ERβ protein expression with clinico-pathological features of EAC

Journal: BMC Cancer

Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression

doi: 10.1186/1471-2407-12-262

Figure Lengend Snippet: Correlation analysis of IGF-1R, IGF-2R, and ERα and ERβ protein expression with clinico-pathological features of EAC

Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China), IGF-2R (polyclonal rabbit anti-human IGF-2R, 1:50 dilution, Wuhan Boster .

Techniques: Expressing

The analysis of the correlation between the mRNA expression of IGFs with ER subtypes in three groups

Journal: BMC Cancer

Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression

doi: 10.1186/1471-2407-12-262

Figure Lengend Snippet: The analysis of the correlation between the mRNA expression of IGFs with ER subtypes in three groups

Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China), IGF-2R (polyclonal rabbit anti-human IGF-2R, 1:50 dilution, Wuhan Boster .

Techniques: Expressing, Control